The IKK NF-κB system: a treasure trove for drug development
Top Cited Papers
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 3 (1), 17-26
- https://doi.org/10.1038/nrd1279
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Thalidomide analogs as emerging anti-cancer drugsAnti-Cancer Drugs, 2003
- TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB PathwayJournal of Molecular Biology, 2003
- NF-κB: arresting a major culprit in cancerDrug Discovery Today, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100Journal of Biological Chemistry, 2002
- Suppression of TNF?-mediated NF?b activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cellsJournal of Cellular Biochemistry, 1999
- The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitroGenes & Development, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Novel cyanoguanidines with potent oral antitumour activityBioorganic & Medicinal Chemistry Letters, 1997
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994